Home » GlaxoSmithKline in Takeover Bid for Human Genome
GlaxoSmithKline in Takeover Bid for Human Genome
GlaxoSmithKline has tabled an offer to take over U.S. drugmaker Human Genome Sciences which values the target at nearly $2.6 billion.
The Kansas City Star
The Kansas City Star
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May